1. Homepage
  2. Equities
  3. Switzerland
  4. Swiss Exchange
  5. Straumann Holding AG
  6. Summary
    STMN   CH1175448666

STRAUMANN HOLDING AG

(STMN)
  Report
Delayed Swiss Exchange  -  05/17 11:30:26 am EDT
121.15 CHF   +2.24%
05/02Mirabaud Securities Lifts Price Target on Straumann, Maintains Buy Recommendation
MT
05/02Mirabaud Securities Lifts Price Target on Straumann, Maintains Buy Recommendation
MT
04/28TRANSCRIPT : Straumann Holding AG, Q1 2022 Sales/ Trading Statement Call, Apr 28, 2022
CI
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Swiss Exchange
05/11/2022 05/12/2022 05/13/2022 05/16/2022 05/17/2022 Date
112.35(c) 110.85(c) 119(c) 118.5(c) 121.15(c) Last
335 248 361 552 623 966 304 615 424 740 Volume
+4.51% -1.34% +7.35% -0.42% +2.24% Change
More quotes
Estimated financial data (e)
Sales 2022 2 324 M 2 341 M 2 341 M
Net income 2022 485 M 488 M 488 M
Net cash position 2022 401 M 404 M 404 M
P/E ratio 2022 38,4x
Yield 2022 0,70%
Sales 2023 2 650 M 2 669 M 2 669 M
Net income 2023 577 M 581 M 581 M
Net cash position 2023 688 M 693 M 693 M
P/E ratio 2023 32,6x
Yield 2023 0,82%
Capitalization 18 889 M 18 815 M 19 028 M
EV / Sales 2022 7,96x
EV / Sales 2023 6,87x
Nbr of Employees 8 873
Free-Float 66,4%
More Financials
Company
Straumann Holding AG is a Switzerland-based company active in the field of implant and restorative dentistry and oral tissue regeneration. In collaboration with clinics, research institutes and universities, the Group researches and develops implants, instruments, computer-aided design/manufacturing (CAD/CAM) prosthetics and tissue regeneration products for use in tooth replacement and restoration solutions or to... 
More about the company
Ratings of Straumann Holding AG
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B
More Ratings
All news about STRAUMANN HOLDING AG
05/02Mirabaud Securities Lifts Price Target on Straumann, Maintains Buy Recommendation
MT
05/02Mirabaud Securities Lifts Price Target on Straumann, Maintains Buy Recommendation
MT
04/28TRANSCRIPT : Straumann Holding AG, Q1 2022 Sales/ Trading Statement Call, Apr 28, 2022
CI
04/28Straumann's Q1 Revenue Grows 25% On Higher Patients Flow
MT
04/28STRAUMANN : reports very strong first quarter
PU
04/28Straumann Holding AG acquired an unknown minority stake in Good Methods Global Inc.
CI
04/20STRAUMANN HOLDING AG : SPLIT: 10 of 1
FA
04/13EINLADUNG : Straumann Group Webcast – Umsatzzahlen 1. Quartal 2022
PU
04/13INVITATION : Straumann Group 2022 first-quarter sales webcast
EQ
04/07STRAUMANN HOLDING AG : Ex-dividend day for final dividend
FA
04/05Straumann Group shareholders elect Nadia Tarolli Schmidt as a new Board member and appr..
EQ
04/05Straumann Holding AG Approves Dividend for the Year 2021, Payable on April 11, 2022
CI
04/01Straumann Group announces new Executive Management Board members to support growth stra..
EQ
04/01Straumann Group Announces Executive Changes
CI
03/04STRAUMANN : supports humanitarian relief efforts in Ukraine
PU
More news
News in other languages on STRAUMANN HOLDING AG
05:31aAKTIEN SCHWEIZ : SMI baut Gewinne aus - Hoffnungen auf Lockerungen in China
05/16AKTIEN SCHWEIZ : SMI vollzieht dank fester Pharma-Schwergewichte Richtungswechsel
05/16AKTIEN SCHWEIZ ERÖFFNUNG : SMI beginnt neue Woche im Rückwärtsgang
05/13BOURSE ZURICH : retour dans le vert pour la dernière séance de la semaine
05/13AKTIEN SCHWEIZ SCHLUSS : SMI schliesst Woche mit kräftiger Gegenbewegung ab
More news
Analyst Recommendations on STRAUMANN HOLDING AG
More recommendations
Stock Trading Strategies
STRAUMANN HOLDING AG - 2021
The technical configuration is positive
BUY
More Stock Trading Analysis
Chart STRAUMANN HOLDING AG
Duration : Period :
Straumann Holding AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends STRAUMANN HOLDING AG
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 14
Last Close Price 118,50 CHF
Average target price 170,46 CHF
Spread / Average Target 43,9%
EPS Revisions
Managers and Directors
Guillaume Daniellot Chief Executive Officer
Peter Hackel Chief Financial Officer
Gilbert Achermann Chief Executive Officer & Director
Christian Ullrich Group Chief Information Officer
Mark D. Johnson Head-Operations, Regulatory & Quality Affairs
Sector and Competitors
1st jan.Capi. (M$)
STRAUMANN HOLDING AG-38.82%18 815
SONOVA HOLDING AG-5.93%20 893
COCHLEAR LIMITED-1.76%9 666
DEMANT A/S-12.29%9 056
EYEBRIGHT MEDICAL TECHNOLOGY (BEIJING) CO., LTD.-14.58%2 783
ANGELALIGN TECHNOLOGY INC.-49.88%2 620